This relates to openness and transparency on the part of our department and specifically our branch. We do have a number of initiatives to move forward in that area. At the moment, we already make available publicly product monographs for each drug that is approved. Those can be found on the Health Canada website. Those documents outline the conditions of use and the risks and benefits for the particular products.
In addition, we make available what is called a summary basis of decision for many drugs and medical devices that are approved through the priority review process. Those documents are meant to be a complement to the product monograph and outline the basis on which we made our decision to approve the products.
As recently as September we—